Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RGNX · against 476 other Healthcare companies of similar size
Ranked #444 of 477 · scores higher than 7% of peers · safety percentile 8
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)48 peers with a safety percentile of 0–9, including RGNX · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RGNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 443 reported | 3.49× | 0.18× | 2% | 33% | |
| BetaLower is better · 457 reported | 0.93 | 0.42 | 22% | 33% | |
| Current ratioHigher is better · 472 reported | 2.86× | 2.83× | 51% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 440 | 952M USD | 8 | 3 | |
| 441 | 303M USD | 8 | 27 | |
| 442 | 2.3B CNY (≈$322M) | 8 | 10 | |
| 443 | 338M USD | 8 | ||
| 444 | 504M USD | 8 | 24 | |
| 445 | 251M EUR (≈$276M) | 7 | 52 | |
| 446 | 2.9B CNY (≈$412M) | 7 | 22 | |
| 447 | 334M USD | 7 | 53 | |
| 448 | 3.4B SEK (≈$337M) | 6 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score